Private Advisor Group’s AC Immune ACIU Stock Holding History

Private Advisor Group’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,600	Closed	-$48K	–	2624
2025 Q3	$48K	Buy	+16,600	New	+$37.5K	﹤0.01%	2453

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Private Advisor Group's ACIU Position: Q4 2025 in Review

Private Advisor Group sold out of AC Immune (ACIU) in Q4 2025, closing a stake of 16,600 shares — an estimated $48K sold.

Private Advisor Group first reported a position in ACIU in Q3 2025 and held it in 1 quarter. The position peaked at $48K in Q3 2025. 41 funds tracked by Wall St. Rank hold ACIU as of Q4 2025.

Private Advisor Group reported no remaining AC Immune position as of Q4 2025 after selling out during the quarter.
Private Advisor Group sold 16,600 AC Immune shares in Q4 2025, an estimated $48K.
Private Advisor Group first reported a position in AC Immune in Q3 2025 and held it in 1 quarter.
Private Advisor Group's AC Immune position peaked at $48K in Q3 2025.
41 funds tracked by Wall St. Rank held AC Immune as of Q4 2025.

Based on Private Advisor Group's 13F filing for Q4 2025, filed 17 Feb 2026.